OKYO Pharma Ltd ADR (OKYO) — Cash Flow-to-Debt Ratio
OKYO Pharma Ltd ADR (OKYO) has a Cash Flow-to-Debt Ratio of -0.51x as of June 2026, meaning its operating cash flow of $-4.41 Million could theoretically repay -1% of its total liabilities ($8.64 Million) in one year. See OKYO Pharma Ltd ADR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OKYO Pharma Ltd ADR Cash Flow-to-Debt Ratio (2008–2026)
Historical debt coverage capacity for OKYO Pharma Ltd ADR across 19 annual periods. For the full cash flow conversion analysis, see OKYO Pharma Ltd ADR cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for OKYO Pharma Ltd ADR (2008–2026)
Year-by-year debt coverage analysis for OKYO Pharma Ltd ADR. Check OKYO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.69x | $-5.94 Million | $8.64 Million | ▼ -250.0% |
| 2025 | -0.20x | $-1.81 Million | $9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | $-9.49 Million | $7.42 Million | ▼ -20.6% |
| 2023 | -1.06x | $-7.70 Million | $7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | $-5.47 Million | $1.35 Million | ▼ -347.4% |
| 2021 | -0.90x | $-1.60 Million | $1.77 Million | ▲ +44.6% |
| 2020 | -1.63x | $-1.20 Million | $737.20K | ▲ +65.0% |
| 2019 | -4.66x | $-1.99 Million | $426.72K | ▲ +73.4% |
| 2018 | -17.51x | $-1.59 Million | $91.06K | ▼ -595.9% |
| 2017 | -2.52x | $-651.27K | $258.76K | ▲ +29.9% |
| 2016 | -3.59x | $-650.88K | $181.34K | ▲ +61.7% |
| 2015 | -9.38x | $-1.42 Million | $151.07K | ▲ +32.6% |
| 2014 | -13.93x | $-3.45 Million | $247.95K | ▲ +33.2% |
| 2013 | -20.85x | $-3.82 Million | $183.32K | ▼ -271.7% |
| 2012 | -5.61x | $-4.67 Million | $832.89K | ▲ +66.3% |
| 2011 | -16.63x | $-1.31 Million | $78.74K | ▼ -51.2% |
| 2010 | -11.00x | $-878.61K | $79.87K | ▼ -317.7% |
| 2009 | -2.63x | $-226.35K | $85.96K | ▲ +25.8% |
| 2008 | -3.55x | $-513.95K | $144.86K | — |